A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
University of Colorado Hospital
Principal Investigator
Lisa Forman, MD
Study ID
Protocol Number: 19-0444
More information available at ClinicalTrials.gov: NCT03742973
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers